Alaunos Therapeutics Inc (TCRT)
1.92
-0.03
(-1.56%)
USD |
NASDAQ |
Dec 24, 11:33
Alaunos Therapeutics Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Microbot Medical Inc | 0.633M |
| SELLAS Life Sciences Group Inc | 19.69M |
| Galectin Therapeutics Inc | 10.00M |
| Oragenics Inc | 3.766M |
| Anavex Life Sciences Corp | 4.55M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.781M |
| Free Cash Flow | -11.76M |
| Free Cash Flow Per Share (Quarterly) | -0.4877 |
| Free Cash Flow Yield | -382.6% |